Veracyte (VCYT) Gains from Investment Securities (2012 - 2026)
Veracyte (VCYT) posted Gains from Investment Securities of $9.4 million for Q1 2026, up 131.28% sequentially from -$29.9 million in Q4 2025, and up 579.22% YoY from $1.4 million in Q1 2025.
Veracyte (VCYT) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Veracyte (VCYT) has 15 years of Gains from Investment Securities data on file, last reported at $9.4 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 579.22% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 466.52% YoY) and the FY2025 annual result came in at -$15.3 million, down 1351.64% from the prior year.
- Gains from Investment Securities climbed to $9.4 million in Q1 2026 per VCYT's latest filing, from -$29.9 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $14.7 million in Q3 2025, with the low at -$29.9 million in Q4 2025.
- Average Gains from Investment Securities over 5 years is -$414294.1, with a median of -$30000.0 recorded in 2024.
- Year-over-year, Gains from Investment Securities soared 2394.83% in 2022 and plunged 6413.33% in 2025.
- Veracyte's Gains from Investment Securities stood at $3.2 million in 2022, then tumbled by 263.51% to -$5.2 million in 2023, then surged by 125.79% to $1.4 million in 2024, then sank by 2312.86% to -$29.9 million in 2025, then soared by 131.28% to $9.4 million in 2026.
- Business Quant data shows VCYT's Gains from Investment Securities at $9.4 million in Q1 2026, -$29.9 million in Q4 2025, and $14.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.36 Mn |
| Mar 31, 2026 | 9.36 Mn |
| Dec 31, 2025 | -29.94 Mn |
| Dec 31, 2025 | -29.94 Mn |
| Sep 30, 2025 | 14.66 Mn |
| Sep 30, 2025 | 14.66 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | -1.95 Mn |
| Mar 31, 2025 | -1.95 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -1.34 Mn |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | -30,000.00 |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | -5.25 Mn |
| Dec 31, 2023 | -5.25 Mn |